Outcomes in hospitalized kidney transplant patients with a penicillin allergy label in the United States, 2005-2014

J Allergy Clin Immunol Pract. 2022 Mar;10(3):867-869.e2. doi: 10.1016/j.jaip.2021.10.015. Epub 2021 Oct 18.

Authors

Jared Nelson¹, Ismael Carrillo-Martin², Wendelyn Bosch¹, Lisa Brumble¹, Justin M Oring¹, Miguel A Park³, Alexei Gonzalez-Estrada⁴

Affiliations

¹ Division of Infectious Diseases, Mayo Clinic, Jacksonville, Fla.
² Division of Pulmonary, Allergy, and Sleep Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Fla.
³ Division of Allergic Diseases, Mayo Clinic, Rochester, Minn.
⁴ Division of Pulmonary, Allergy, and Sleep Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Fla. Electronic address: [email protected].

PMID: 34673288
DOI: 10.1016/j.jaip.2021.10.015

No abstract available

MeSH terms

Anti-Bacterial Agents / adverse effects
Delivery of Health Care
Drug Hypersensitivity* / diagnosis
Drug Hypersensitivity* / epidemiology
Humans
Kidney Transplantation*
Penicillins / adverse effects
United States / epidemiology

Substances

Anti-Bacterial Agents
Penicillins